Delivery Order SPE2DB25D3003-SPE2DB25FPVRP

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,052.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 30 MG CAPSULES 100S, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 10, 2024. The contract was awarded on December 9, 2024 and was not designated with a...
This federal contract award, valued at $8,657.86, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of VYVANSE CAPS 30MG, a pharmaceutical product, with a completion date of January 24, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA, which serves as a primary vehicle for the company...
This federal contract award, valued at $1,337.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 20, 2024. This contract award is not associated with a set-aside designation, indicating...
This federal contract award, valued at $3,148.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a completion date of October 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
The federal contract award, valued at $23,974.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This firm fixed price delivery order is for the supply of VYVANSE CAPS 60MG, a specialty pharmaceutical product. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) valued...
This contract award, valued at $7,000.36, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565841156 VYVANSE 30 MG CAPSULE 100S, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of September 18, 2024. The contract has no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,700.16 firm-fixed-price delivery order is for the supply of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of VYVANSE 20 MG CAPSULE 100S. The contract is a Delivery Order with a Firm Fixed Price of $2,675.40 and an ultimate completion date of January 29, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $3,601.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through January 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,732.93, is a Delivery Order for the supply of VYVANSE 50 MG CAPSULE 100S, a specialty medication. The contract has a firm fixed price and an ultimate completion date of December 19, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen...
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPVRP
    Delivery Order

This federal contract award, valued at $3,882.92, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order, is for the supply of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of February 3, 2025. This contract award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/2/25, 10:00 AM